The potential functional significance of human 1,25-dihydroxyvitamin D3 [1, 25(OH) 
ily that have been shown to exist as phosphoproteins include the progesterone receptor, glucocorticoid receptor (GR), thyroid hormone receptor, estrogen receptor, androgen receptor (reviewed in ref. 3) , as well as the 1,25-dihydroxyvitamin D3 [1, 25(OH) 2D3] receptor (VDR) (4) (5) (6) . Biochemical analysis has revealed that a majority of the sites phosphorylated in these receptors are serine residues. Based on kinase consensus recognition sequences and in vitro assays, several kinases have been implicated in the phosphorylation of nuclear receptors, including proline-directed kinase, calcium-calmodulindependent kinase, DNA-dependent protein kinase, protein kinase A, and protein kinase C (reviewed in ref. 7) . Another kinase of potential significance in terms of steroid hormone receptor phosphorylation is casein kinase II (CK-II). This latter enzyme, a predominantly nuclear-localized kinase (8) , is present in a wide variety of eukaryotic cells (9) and is known to phosphorylate nuclear oncogene products and a number of proteins involved in gene expression such as RNA polymerases I and II, c-myc, c-myb, and max (10) . CK-II has also been implicated in the phosphorylation of steroid/thyroid hormone receptors including the thyroid hormone receptor (11) , estro- The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
gen receptor (12) , and progesterone receptor (13) . We have previously reported that the human VDR (hVDR) is phosphorylated by CK-II in vitro at Ser-208, a CK-II consensus recognition site, and that this residue represents the predominant endogenous hVDR phosphorylation site in transfected COS-7 cells (14) . Using a similar approach of hVDR overexpression in COS-1 cells, Hilliard et al. (15) (17) , nuclear localization (18) , and transcriptional activation (19, 20) . However, recent probing of the significance of five to seven GR phosphorylation sites in or near the N-terminal transactivation domain, one of which is a CK-II consensus site, reveals that they are not absolutely essential for stimulation of transcription by the hormonal ligand (21, 22) . Thus, the mechanistic implications of steroid hormone receptor phosphorylation remain unclear, and direct evidence for modulation of receptor activity by phosphorylation of these proteins at a specific residue(s) by a particular kinase has been difficult to obtain. This paper presents an analysis of the functional consequences of CK-II-mediated phosphorylation of hVDR. (26) and monitored for hVDR by immunoblotting using the 9A73y monoclonal anti-VDR antibody (27 (26) . RESULTS Phosphorylation of hVDR in COS-7 Cells Overexpressing CK-II. As can be seen in Fig. 1 ..-_-.
MATERIALS AND METHODS
---. (Fig. 2D) . In control experiments, the activity of the thymidine kinase core promoter, without the VDRE, was not affected significantly by transfection of even the highest amount of CK-II (Fig. 2B) (1996) Proc. Natl. Acad. Sci. USA 93 (1996) ylation of Ser-208 ( Fig. 1) and CK-II-mediated enhancement of hVDR transcriptional activity (Fig. 2C) .
Two final control experiments were performed to probe the VDR residue and receptor specificity of CK-II-augmented transactivation. First, transactivation was tested by using a hVDR mutant in which a minimally phosphorylated CK-II consensus residue in the immediate vicinity of Ser-208, namely Ser-203, was altered to an alanine (S203A). Fig. 2C illustrates that in this case 1,25(OH)2D3-stimulated transcription is elevated in response to increasing expression of CK-II similarly to that of the wild-type hVDR. Second, as depicted in Fig. 3 , in the absence of CK-II coexpression, the addition of dexamethasone to GR cotransfected cells results in a 16-to 22-fold enhancement of GRE-dependent transcription (Fig. 3A) , but increasing amounts of transfected CK-II have no significant effect on either dexamethasone-induced transcriptional activation (Fig. 3C) or on basal thymidine kinase promoter activity (Fig. 3B) . Thus, the CK-II-mediated stimulation of transcriptional activation appears to be confined to Ser-208 and specific for the VDR.
DNA-Binding Activity of hVDR Phosphorylated by CK-II in
Transfected COS-7 Cells. Incubation of the rat osteocalcin VDRE and increasing amounts of extract from cells transfected with either the wild-type or S208G mutant hVDR leads to a corresponding and equivalent increase of the VDR-VDRE complex (Fig. 4, (Fig. 5A ) and 0.40 nM (Fig. 5B) , respectively. In a parallel set of experiments, data from extracts of cells cotransfected with either the wild-type or S208G mutant hVDR and CK-II yielded Kd values of 0.52 nM (Fig. 5C ) and 0.55 nM (Fig. 5D) , respectively. These results demonstrate that neither phosphorylation of hVDR by CK-II nor alteration of the Ser-208 residue appreciably influences the affinity of the receptor for the 1,25(OH)2D3 hormone in vitro.
Finally, the subcellular partitioning of the receptor was examined. Quantitative densitometric scanning of the images depicted in Fig. 5E revealed that the specific activity of the wild-type receptor was -2.3-fold greater in the nuclear compartment relative to the cytosolic activity (compare lanes 6 and 8). In the case of the S208G mutant, the specific activity was 1.7-fold greater in the nucleus relative to the specific activity in the cytosol (compare lanes 2 and 4). Most relevant to the present study, the coexpression of CK-II did not alter the specific activity of either the wild-type (compare lanes 5 and 6; lanes 7 and 8) or S208G receptors (compare lanes 1 and 2 and lanes 3 and 4) in either subcellular compartment.
DISCUSSION
Ser-208 of hVDR has been revealed as the major residue phosphorylated by CK-II in vitro and as the predominant endogenous receptor phosphorylation site in transfected COS-7 cells (14) . Furthermore, phosphopeptide mapping studies of hVDR expressed in COS-1 cells point to Ser-208 as the primary phosphorylated amino acid in response to supraphysiologic doses of the 1,25(OH)2D3 hormone (15 (26) (32) .
The VDR is also known to be phosphorylated at Ser-51 by protein kinase C both in vitro and in vivo, resulting in a decrease in the specific interaction between the receptor and the VDRE, yet mutation of this serine to alanine does not affect DNA binding (27) . Similarly, replacement of Ser-208 with alanine or glycine does not markedly attenuate 1,25(OH)2D3-mediated transcriptional activation in.transfected cells. This result suggests that the modest decrease in phosphorylation elicited by alteration of (Fig. 1) is not sufficient to generate detectable parallel changes in transcriptional activity apparently because of low endogenous levels of CK-II. Only under conditions of elevated CK-II activity, as has been suggested to occur in cells exposed to mitogenic stimuli or during certain phases of the cell cycle (10), or by increasing CK-II through supplemental coexpression of the enzyme (Fig.  2C) , can a difference in the transcriptional capacity of the Ser-208 mutant VDR be revealed. We envisage two populations of liganded VDR, one that is hypophosphorylated at Ser-208 yet still active in transcriptional enhancement, and a superactive, hyperphosphorylated form that is even more effective at cooperatively recruiting coactivators and/or basal transcription factors. Therefore, taken together, these observations indicate that posttranslational modification of Ser-208 or -51 is not an obligatory switch for VDR function; rather, these phosphorylations represent both positive (CK-II) and negative (protein kinase C) modulatory mechanisms that apparently govern receptor activity under appropriate cellular conditions. Thus, the composite activity of hVDR may depend on the convergence of integrated inputs from several signal transduction pathways, including CK-II and protein kinase C, through "cross-talk" facilitated by phosphorylation.
